2004
DOI: 10.1007/bf02724106
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal kawasaki disease

Abstract: The authors report a case of Kawasaki disease that manifested in a newborn and presented at the age of 6 weeks of age with coronary artery aneurysms.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0

Year Published

2006
2006
2014
2014

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(14 citation statements)
references
References 6 publications
0
14
0
Order By: Relevance
“…In patients less than 3 months old, Kawasaki disease displays an atypical or incomplete course with persistence of inflammation leading to rapid and severe coronary damage [18,19]. At this age clinicians often miss the diagnosis.…”
Section: Infants and Adultsmentioning
confidence: 99%
“…In patients less than 3 months old, Kawasaki disease displays an atypical or incomplete course with persistence of inflammation leading to rapid and severe coronary damage [18,19]. At this age clinicians often miss the diagnosis.…”
Section: Infants and Adultsmentioning
confidence: 99%
“…The disease is rare in neonatal and infant period. Only 1.6% of patients is under 90 days of age (9). In incomplete cases, coronary involvements are more common because of the delays in diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…The atypical presentations include low incidence of conjunctivitis, skin rash and extremity changes, and low C-reactive protein. [68] Lack of awareness of neonatal occurrence of KD is responsible for delay in diagnosis. Classical presentation of KD such as high-grade fever not relieved by antipyretics, generalized erythematous maculopapular rash, bilaterally symmetrical nonpitting edema of hands and feet, fissuring of lips, reddish discoloration of tongue and non-purulent bilateral bulbar conjunctivitis has been reported.…”
Section: Epidermolysis Bullosamentioning
confidence: 99%
“…[69] Persistence of fever, persistently elevated acute phase reactants (systemic inflammation) and new onset dilatation of coronary arteries are indicators of second dose of IVIg. [68] Newer drugs like infliximab (5 mg/kg over 2 h) have been investigated for safety and tolerability in pediatric patients (youngest, 2 months; oldest 5 years) with KD.…”
Section: Epidermolysis Bullosamentioning
confidence: 99%